Past efforts to collect data and to understand the relationship between minimal residual disease and outcomes will allow help ...

"This is the first reported case of successfully using targeted therapy to treat a CAR-positive T-cell lymphoma," noted ...

Jered Haddad transforms his cancer journey into a mission, cycling in Iceland to raise awareness and funds for multiple ...

A team of researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has successfully treated ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging survival. Patients are living years longer, thanks to novel combination ...

Medically reviewed by Archana Sharma, DO Diagnosing multiple myeloma, also referred to as myeloma, is often a complex process. While this rare blood cancer can cause many complications, it can't ...

Researchers successfully treated a rare and aggressive T-cell lymphoma that developed after CAR T-cell therapy for multiple ...

A bid by GlaxoSmithKline (GSK) to bring its multiple myeloma drug belantamab mafodotin (Blenrep) back to the market hit a stumbling block during an FDA panel meeting held on July 17.

The 2025 Iceland Cycling Expedition supports the International Myeloma Foundation, raising awareness and funds for multiple myeloma research. Ashley Dieks uses cycling as a therapeutic tool, ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple myeloma drug into pivotal trials. The candidate in question, an oral p300 ...